A comprehensive view of Liver / Kidney / Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
CA ACR183: IgA Nephropathy Awareness Day.
Published:
May 06, 2024
by California 2023-2024 Session
|
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non–muscle-invasive bladder cancer, respectively
Published:
May 05, 2024
by Janssen Pharmaceutical Companies
|
Baxter reports first-quarter 2024 results
Published:
May 03, 2024
by Business Wire
|
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non–muscle-invasive bladder cancer
Published:
May 03, 2024
by Janssen Pharmaceutical Companies
|
Commentary: Liver health emerges as fastest-growing positioning in Asia Pacific dietary supplements market, with 2020-2023 CAGR of 23.7%; young Asians interested in liver health amid trend of imbalanced dietary habits, occasional unhealthy indulgences
Published:
May 02, 2024
by Euromonitor International Ltd.
|
Ask us about our R&D/Patents market view